Alumis Inc. ALMS
5.08 USD -0.52 (-9.29%)
As ofNov 16, 2026, 12:28 PM EST
5.04 Day range 5.80
5.04 52-week range 31.35
- YTD
- -47.95%
- 1 year
- -7.97%
News
benzinga.com Oppenheimer Maintains Outperform on Alumis, Lowers Price Target to $28 Oppenheimer analyst Jeff Jones maintains Alumis (NASDAQ:ALMS) with a Outperform and lowers the price target from $37 to $28.
benzinga.com Wells Fargo Maintains Overweight on Alumis, Lowers Price Target to $18 Wells Fargo analyst Derek Archila maintains Alumis (NASDAQ:ALMS) with a Overweight and lowers the price target from $25 to $18.
benzinga.com HC Wainwright & Co. Maintains Buy on Alumis, Lowers Price Target to $9 HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Alumis (NASDAQ:ALMS) with a Buy and lowers the price target from $15 to $9.
globenewswire.com Alumis Reports Third Quarter 2026 Financial Results and Highlights Recent Business Updates – New Phase 3 data demonstrated rapid and durable improvements in plaque psoriasis burden, adding to envudeucitinib's differentiated clinical profile, including the highest publicly reported Week 48…
